- Home
- WOR vs CRNX Comparison
WOR vs CRNX Comparison
Compare WOR & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WOR
- CRNX
- Stock Information
- Founded
- WOR 1955
- CRNX 2008
- Country
- WOR United States
- CRNX United States
- Employees
- WOR N/A
- CRNX N/A
- Industry
- WOR Aerospace
- CRNX Biotechnology: Pharmaceutical Preparations
- Sector
- WOR Consumer Discretionary
- CRNX Health Care
- Exchange
- WOR Nasdaq
- CRNX Nasdaq
- Market Cap
- WOR 2.7B
- CRNX 2.8B
- IPO Year
- WOR N/A
- CRNX 2018
- Fundamental
- Price
- WOR $56.35
- CRNX $44.43
- Analyst Decision
- WOR Buy
- CRNX Buy
- Analyst Count
- WOR 3
- CRNX 12
- Target Price
- WOR $61.00
- CRNX $74.45
- AVG Volume (30 Days)
- WOR 378.3K
- CRNX 2.1M
- Earning Date
- WOR 09-23-2025
- CRNX 11-06-2025
- Dividend Yield
- WOR 1.21%
- CRNX N/A
- EPS Growth
- WOR 179.34
- CRNX N/A
- EPS
- WOR 2.14
- CRNX N/A
- Revenue
- WOR $1,200,161,000.00
- CRNX $1,392,000.00
- Revenue This Year
- WOR $14.93
- CRNX $469.59
- Revenue Next Year
- WOR $4.45
- CRNX $705.27
- P/E Ratio
- WOR $26.36
- CRNX N/A
- Revenue Growth
- WOR 0.76
- CRNX 0.51
- 52 Week Low
- WOR $37.88
- CRNX $24.10
- 52 Week High
- WOR $70.91
- CRNX $62.53
- Technical
- Relative Strength Index (RSI)
- WOR 36.07
- CRNX 64.10
- Support Level
- WOR $54.65
- CRNX $40.33
- Resistance Level
- WOR $56.63
- CRNX $47.41
- Average True Range (ATR)
- WOR 1.49
- CRNX 2.21
- MACD
- WOR -0.07
- CRNX 0.24
- Stochastic Oscillator
- WOR 42.28
- CRNX 63.57
About WOR Worthington Enterprises Inc.
Worthington Enterprises Inc is a designer and manufacturer of products and services, including manufactured metal products. The company operates under two reportable operating segments: Consumer Products and Building Products. The consumer Products business has a diverse product offering in the tools, outdoor living and celebrations categories, including propane-filled cylinders for torches, handheld torches, specialized hand tools, drywall tools, accessories and gas grills, and others. And the Building Products business engaged in providing pressurized containment solutions, providing critical components in the residential, non-residential, and repair and remodel end markets through essential categories. The company derives majority of the revenue from Building Products segment.
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.